You just read:

Truvian Sciences Accelerates Plans With $27.1 Million Series B Financing to Develop an Automated Benchtop Blood Testing System for Rapid Assessment of a Full Suite of Health Tests

News provided by

Truvian Sciences

Nov 20, 2019, 07:00 ET